TABLE 1.
Characteristics of HSCT recipients and grafts
| Patient characteristics | |
| Age (years) | 41 (31–49) |
| Less than 40 | 434 (47) |
| 40 or older | 480 (53) |
| Male | 502 (55) |
| Race, in order of frequency | |
| White | 743 (82) |
| Asian/Pacific Islander | 51 (6) |
| Hispanic | 50 (6) |
| Black | 13 (1) |
| Native American | 13 (1) |
| Other | 33 (4) |
| Transplant characteristics | |
| Stem cell sources | |
| Bone marrow | 598 (65) |
| Peripheral blood | 311 (34) |
| Both of the above | 5 (1) |
| Second transplant | 21 (2) |
| Stem cell donor | |
| Related, HLA matched | 428 (47) |
| Related, HLA mismatched | 55 (6) |
| Unrelated | 431 (47) |
| CMV discordant, donor positive | 134 (15) |
| Dose of TBI | |
| No irradiation | 385 (42) |
| 12 Gy | 256 (28) |
| More than 12 Gy | 273 (30) |
| Methotrexate used | 874 (96) |
| Acute GVHD | |
| None | 145 (16) |
| Grade I–II | 537 (59) |
| Grade III–IV | 229 (25) |
| Days to engraftment (n = 879)† | 19 (16–23) |
*
Data are reported as median (IQR) or number (%).
†
Data were missing for 1% or less of records unless otherwise noted.